Elise Weerts, Ph.D.

Interactions of Delta-9 Tetrahydrocannabinol

July 11, 2024, 1:00 PM

Dr. Weerts is a Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and core faculty in the preclinical Division of Behavioral Biology (DBB) the Behavioral Pharmacology Research Unit (BPRU) for human clinical and laboratory research.  She has over 25 years of experience conducting behavioral pharmacology, drug pharmacokinetics and neuroimaging research in both laboratory animals and human volunteers. Dr. Weerts  has been continuously funded by the NIH since 2001, and cannabis/cannabinoids are a main focus of her current research. She has conducted multiple behavioral pharmacology studies comparing the effects of cannabis and isolated cannabinoids administered via different routes of administration on conditioned reward, pain sensitivity, inflammation, anxiety-like behaviors and cognition.  Dr. Weerts has refined and validated methodologies for rodent THC vapor exposure using e-vape technology with concurrent pharmacokinetic analyses to establish parameters for THC vapor exposure sufficient to produce significant plasma concentrations of cannabinoids in rats that were comparable to those in human laboratory studies.  Her recent PET imaging study in human volunteers was one of the first to demonstrate changes in the cannabinoid receptor type 1 (CB1R) associated with regular cannabis use in women and reveal differences in CB1R availability in healthy men and women who do not use cannabis. Dr. Weerts  has served on multiple study sections for NIH institutes (NIDA, NIAAA and CSR) as a section member and as Chair., and also serves on the Editorial Boards for several journals including Addiction Biology, Pharmacology Biochemistry and behavior, and Experimental and Clinical Psychopharmacology.  

https://youtu.be/hQoTmsgpre0

Previous Webinars

Dmitry Kurouski, PhD

Raman spectroscopy-assisted diagnosis of cannabis physiological differences

July 17th, 11:00AM MST

Dmitry Kurouski earned his MS in Biochemistry from Belarusian State University, Belarus and PhD (Distinguished Dissertation) in Analytical Chemistry from SUNY Albany, NY, USA. After a Postdoc in the laboratory of Professor Richard P. Van Duyne at Northwestern University, Dr Kurouski joined BoehringerIngelheim Pharmaceuticals, […]

Read More »

Elise Weerts, Ph.D.

Interactions of Delta-9 Tetrahydrocannabinol

July 11, 2024, 1:00 PM

Dr. Weerts is a Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and core faculty in the preclinical Division of Behavioral Biology (DBB) the Behavioral Pharmacology Research Unit (BPRU) for human clinical and laboratory research.  She has […]

Read More »

Felipe Sarmiento Salazar, PhD

Flowering modulation in Cannabis sp. by night
interruption

June 19, 2024 11:00AM MT

Dr. Felipe Sarmiento Salazar is a biologist graduated from the Universidad de los Andes, doctor in Biology from the University of Freiburg and professor at the Department of Biology of the National University of Colombia since 2016. Professor Sarmiento has extensive experience in […]

Read More »

Ken Olejar, PhD

Cannabinoid extraction and modification: Current and future trends

May 15th, 11:00 AM MST

Dr Ken Olejar is a Research Associate at Colorado State University – Pueblo and the founder of AgriBioactive Consulting. He obtained his MSc in Pharmaceutical Science from the University of Florida and his PhD in Analytical Chemistry from The University of Auckland, New […]

Read More »

Ethan Russo, MD

Limonene, THC, Herbal Synergy and the Entourage Effect

June 13, 2024, 1:00PM MT

Ethan Russo, MD, is a board-certified child and adult neurologist(1987), psychopharmacologist, and Founder/CEO of CReDO Science. He is also Chief Medical Officer to Andira Pharmaceuticals, Senior Medical Advisor to Canurta, and Medical Director of Breeder’s Best. He was Director of R&D for the […]

Read More »